The addition of an angiotensin-converting enzyme (ACE) inhibitor did not decrease risk for chemotherapy-related cardiac damage in patients being treated for breast cancer and non-Hodgkin lymphoma […]

Lerodalcibep, a novel, third-generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, reduced low-density lipoprotein cholesterol (LDL-C) by more than 50% after 1 year in patients with […]

Alcohol-mediated renal denervation (RDN) significantly reduces 24-hour ambulatory systolic blood pressure (SBP) in patients with uncontrolled hypertension, results of a new phase 3 trial showed. But […]

A home-based exercise program plus protein supplementation was safe for frail older adults undergoing transcatheter aortic valve replacement (TAVR) and improved strength, mobility, and balance compared […]

Cholesterol lowering with a strategy using the short interfering RNA agent, inclisiran, earlier in the treatment pathway led to significantly better long-term low-density lipoprotein (LDL) reduction […]

ATLANTA, GA — A multicenter controlled trial testing the ability of an aldose reductase inhibitor to stabilize early-stage asymptomatic diabetic cardiomyopathy missed its primary endpoint, researchers […]

ATLANTA, GA — Younger, low-risk patients with aortic stenosis who need aortic valve replacement may now be able to consider a less invasive transcatheter approach rather […]

In patients with acute coronary syndrome (ACS), intravascular ultrasound (IVUS)-guided implantation of a drug-eluting stent improved outcomes compared with angiography guidance alone. “Our study included all […]